Davies NM, Takemoto JK, Brocks DR, Yáñez JA. Multiple peaking phenomena in pharmacokinetic disposition. Clin Pharmacokinet. 2010;49:351–77. https://doi.org/10.2165/11319320-000000000-00000.

Article  CAS  PubMed  Google Scholar 

Godfrey KR, Arundel PA, Dong Z, Bryant R. Modelling the double peak phenomenon in pharmacokinetics. Comput Methods Progr Biomed. 2011;104(2):62–9. https://doi.org/10.1016/j.cmpb.2010.03.007.

Article  Google Scholar 

Cristofoletti R, Rowland M, Lesko LJ, Blume H, Rostami-Hodjegan A, Dressman JB. Past, present, and future of bioequivalence: improving assessment and extrapolation of therapeutic equivalence for oral drug products. J Pharm Sci. 2018;107(10):2519–30. https://doi.org/10.1016/j.xphs.2018.06.013.

Article  CAS  PubMed  Google Scholar 

Brocks DR, Upward JW, Georgiou P, Stelman G, Doyle E, Allen E, et al. The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers. Eur J Clin Pharmacol. 1996;51:303–8. https://doi.org/10.1007/s002280050202.

Article  CAS  PubMed  Google Scholar 

Yousef M, Park C, Le TS, Chacra NB, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolut Technol. 2022;29:86–93. https://doi.org/10.14227/DT290222P86.

Article  CAS  Google Scholar 

Yousef M, Silva D, Chacra NB, Davies N, Löbenberg R. The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences. J Pharm Pharm Sci. 2021;24:533–47. https://doi.org/10.18433/jpps32222.

Article  CAS  PubMed  Google Scholar 

Yousef M, Chacra NB, Löbenberg R, Davies NM. Understanding lymphatic drug delivery through chylomicron blockade: a retrospective and prospective analysis. J Pharmacol Toxicol Methods. 2024. https://doi.org/10.1016/j.vascn.2024.107548.

Article  PubMed  Google Scholar 

Brocks DR, Davies NM. Lymphatic drug absorption via the enterocytes: pharmacokinetic simulation, modeling, and considerations for optimal drug development. J Pharm Pharm Sci. 2018;21(1s):254s-s270. https://doi.org/10.18433/jpps30217.

Article  PubMed  Google Scholar 

Brocks DR, Upward J, Hust R, Köester FE, Collie H, Qian Y, et al. The pharmacokinetics of pranlukast in healthy young and elderly subjects. Int J Clin Pharmacol Ther. 1996;34(9):375–9.

CAS  PubMed  Google Scholar 

Brocks DR, Upward J, Davy M, Howland K, Compton C, McHugh C, et al. Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers. Br J Clin Pharmacol. 1997;44(3):289–91. https://doi.org/10.1046/j.1365-2125.1997.00650.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prajapati KJ, Kothari CS. Isolation, characterization, and toxicity study of stress degradation products of pranlukast hydrate. Chem Res Toxicol. 2022;35(7):1206–19. https://doi.org/10.1021/acs.chemrestox.1c00222.

Article  CAS  PubMed  Google Scholar 

Ha E-S, Baek I-H, Yoo J-W, Jung Y, Kim M-S. Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization. Drug Des Dev Ther. 2015. https://doi.org/10.2147/DDDT.S87738.

Article  Google Scholar 

Saals BADF, De Bie TH, Osmanoglou E, van de Laar T, Tuin AW, van Orten-Luiten ACB, et al. A high-fat meal significantly impacts the bioavailability and biphasic absorption of cannabidiol (CBD) from a CBD-rich extract in men and women. Sci Rep. 2025;15(1):3678. https://doi.org/10.1038/s41598-025-87621-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zgair A, Lee JB, Wong JCM, Taha DA, Aram J, Di Virgilio D, et al. Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation. Sci Rep. 2017;7(1):14542. https://doi.org/10.1038/s41598-017-15026-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fabritius M, Staub C, Mangin P, Giroud C. Distribution of free and conjugated cannabinoids in human bile samples. Forensic Sci Int. 2012;223(1–3):114–8. https://doi.org/10.1016/j.forsciint.2012.08.013.

Article  CAS  PubMed  Google Scholar 

Attili-Qadri S, Karra N, Nemirovski A, Schwob O, Talmon Y, Nassar T, et al. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Proc Natl Acad Sci USA. 2013;110(43):17498–503. https://doi.org/10.1073/pnas.1313839110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li F, Hu R, Wang B, Gui Y, Cheng G, Gao S, et al. Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake. Acta Pharm Sin B. 2017;7(3):353–60. https://doi.org/10.1016/j.apsb.2017.02.002.

Article  PubMed  PubMed Central  Google Scholar 

Valicherla GR, Dave KM, Syed AA, Riyazuddin M, Gupta AP, Singh A, et al. Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. Sci Rep. 2016;6(1):26895. https://doi.org/10.1038/srep26895.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun M, Zhai X, Xue K, Hu L, Yang X, Li G, et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci. 2011;43(3):132–40. https://doi.org/10.1016/j.ejps.2011.04.011.

Article  CAS  PubMed  Google Scholar 

Liao H, Gao Y, Lian C, Zhang Y, Wang B, Yang Y, et al. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems. Int J Nanomed. 2019. https://doi.org/10.2147/IJN.S214883.

Article  Google Scholar 

Jitta SR, Salwa, Bhaskaran NA, Marques SM, Kumar L, Cheruku SP, et al. Enhanced tissue distribution of ritonavir-loaded nanostructured lipid carriers-recommending its dose reduction. Drug Deliv Transl Res. 2023. https://doi.org/10.1007/s13346-023-01386-9.

Article  PubMed  Google Scholar 

Tang T-T, Hu X-B, Liao D-H, Liu X-Y, Xiang D-X. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. Int J Nanomed. 2013. https://doi.org/10.2147/IJN.S51469.

Article  Google Scholar 

Xu Q, Zhou A, Wu H, Bi Y. Development and in vivo evaluation of baicalin-loaded W/O nanoemulsion for lymphatic absorption. Pharmaceut Dev Technol. 2019;24(9):1155–63. https://doi.org/10.1080/10837450.2019.1646757.

Article  CAS  Google Scholar 

Elsheikh MA, Elnaggar YSR, Hamdy DA, Abdallah OY. Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine berberine chloride: optimization and pharmacokinetics. Int J Pharm. 2018;535(1–2):316–24. https://doi.org/10.1016/j.ijpharm.2017.11.023.

Article  CAS  PubMed  Google Scholar 

Ghassemi S, Haeri A, Shahhosseini S, Dadashzadeh S. Labrasol-enriched nanoliposomal formulation: novel approach to improve oral absorption of water-insoluble drug, carvedilol. AAPS PharmSciTech. 2018;19:2961–70. https://doi.org/10.1208/s12249-018-1118-9.

Article  CAS  PubMed  Google Scholar 

Makwana V, Jain R, Patel K, Nivsarkar M, Joshi A. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm. 2015;495(1):439–46. https://doi.org/10.1016/j.ijpharm.2015.09.014.

Article  CAS  PubMed  Google Scholar 

Ravi PR, Aditya N, Kathuria H, Malekar S, Vats R. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in-vivo evaluation and uptake mechanism. Eur J Pharm Biopharm. 2014;87(1):114–24. https://doi.org/10.1016/j.ejpb.2013.12.015.

Article  CAS  PubMed  Google Scholar 

Khan AA, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomed. 2013;8:2733. https://doi.org/10.2147/IJN.S41521.

Article  CAS  Google Scholar